Navigation Links
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Date:5/20/2008

Data from WELCOME Study Presented at Digestive Disease Week (DDW)

SAN DIEGO, May 20 /PRNewswire/ -- UCB today presented data at the Digestive Disease Week meeting that showed Cimzia(R) (certolizumab pegol) provided an effective and rapid clinical response in more than 60 percent of Crohn's disease patients who were intolerant, or no longer responding to infliximab. Over 39 percent of patients achieved remission by six weeks. Data also showed one-third of patients responded after receiving only the initial dose. [Abstract #494]

"Data from the UCB clinical trials program including the WELCOME and PRECiSE studies has demonstrated that certolizumab pegol is effective in inducing and sustaining clinical response in a broad range of patients with moderate to severe Crohn's disease," said David G. Binion, M.D., director, IBD Center and professor of medicine at the Medical College of Wisconsin in Milwaukee, Wis. "The addition of Cimzia(R) into our pharmacologic armamentarium to control chronic intestinal inflammation is an important advance for patients who suffer from Crohn's disease."

Cimzia(R) is the first and only PEGylated anti-TNFa (Tumor Necrosis Factor alpha) antibody approved for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have an inadequate response to conventional therapy. Cimzia(R), manufactured by UCB, was approved by the U.S. Food and Drug Administration (FDA) on April 22, 2008. The approval was based on safety and efficacy data from clinical trials in more than 1,500 patients with Crohn's disease.

The response rates in this study, measured by a decrease (greater than or equal to 100 points from baseline) in the Crohn's Disease Activity Index (CDAI) score, were comparable to those in an earlier study, the PRECiSE 2 trial, where 64 percent of patients in the overall population achieved response to Cimzia(R).

Cimzia(R) was
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers
2. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
3. AlphaRx Provides Corporate and Development Update
4. PA Health Department Provides Hepatitis B Vaccinations, Discusses Risk Factors
5. Cipher provides regulatory update for CIP-TRAMADOL ER
6. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
7. InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results
8. Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain
9. Dubai Provides Aid for Cyclone Nargis Victims In Myanmar
10. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
11. Cholera study provides exciting new way of looking at infectious disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 On October ... Minds featuring skin diseases both fictional and real. ... (CEHMDF), a nonprofit organization committed to advocacy and philanthropy ... CBS will take the opportunity to impart truth and ... , There are many misconceptions about Morgellons ...
(Date:10/22/2014)... Norton HealthDay Reporter , TUESDAY, ... the three Ebola cases in Dallas. But, mental health specialists ... Americans. President Barack Obama on Friday appointed an Ebola ... has infected two Dallas nurses who cared for a Liberian ... Presbyterian Hospital. But the U.S. cases are miniscule in ...
(Date:10/22/2014)... Hay House is pleased to announce the ... Your Life (Paperback; $10.82) written by the highly esteemed Tommy ... This book is meant to help readers of all kinds ... , Recovery 2.0 is not the average self-help book, ... a guide for what comes next. For many, ...
(Date:10/22/2014)... Healthcare professionals who are looking for ... home or on-the-go via laptops, tablets or mobile ... premium Seminar-on-Demand CE courses. The new courses add ... hours of CE course offerings, allowing therapy ... such a diverse library, there’s something for everyone. ...
(Date:10/22/2014)... 2014 Richard Carlson, Managing Partner of ... with over 25 years experience. Mr. Carlson is ... areas related to EDI, B2B Commerce, RFID and Internet/Intranet ... Advisory Board member for Pharmaceutical Commerce Magazine and a ... Group is a management and technology consulting firm focused ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2
... for health services were meant to motivate health care workers ... in Healthcare. According to researchers, these // ... keep manipulation tactics at bay. ,Gwyn Bevan and ... lauded the target based assessment, but have gone further to ...
... of breast cancer or those who suspect it, feel awkward to ... // ,The Prof says that in the UK alone, the ... and nearly 70 succumb to it. This is also because nearly ... to an irrevocable stage. ,Men should watch out for a ...
... International Journal of Cancer on February 17, 2006 tries to ... the level of physical activity in women. // The prospective ... link. ,Experts felt that since exercise is known ... the gastrointestinal transit time, it might also play a constructive ...
... to reduce smoking amongst children have been lauded with a ... an added thrust to the campaign.// Smoking hampers their ... the drive, by augmenting the anti-smoking budget, Hawaii has regressed ... cigarettes have not been hiked, unfortunately, which might have deterred ...
... Research seems to compliment Acupressure over physical therapy, to ... Taiwan University // have acclaimed Acupressure’s success with statistics ... to physical therapy with the effect lasting up to ... pain were treated with six sessions of acupressure, and ...
... to curb the spread of AIDS/HIV, which is haunting the ... authorities from over 20 different countries in the Asia Pacific ... a universal access to AIDS/HIV treatment and prevention would be ... the failure of the WHO target to expand AIDS treatment ...
Cached Medicine News:Health News:Women, Exercise and Colon Cancer 2
(Date:10/25/2014)... ARBOR, Mich. , Oct. 24, 2014 Advanced ... second quarter (ending September 26, 2014) financial results on Monday, ... will be released after the close of the market and ... discuss the results at 4:30 p.m. EDT on the same ... Richard Kurtz (CEO and Director), Rob Risser ...
(Date:10/25/2014)... , Oct. 24, 2014  The National ... the latest results achieved by Kentucky,s ... The National Precursor Log Exchange ... the point of sale and helps flag meth ... agents often set up NPLEx "watch lists" that ...
(Date:10/25/2014)... DUBLIN , October 24, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/wdq92g/global_and ) has announced the addition ... Industry Report 2014"  report to their ... ,The Global and Chinese Acne Medication Industry ... study on the current state of the ...
Breaking Medicine Technology:Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2Kentucky's NPLEx Technology Making Significant Progress 2Global and Chinese Acne Medication Industry Report 2014 2Global and Chinese Acne Medication Industry Report 2014 3
... SphygmoCor system plays key role in discovery, ... A,new study of more than 10,000 patients, conducted ... United Kingdom using AtCor Medical Holdings,Limited,s SphygmoCor(R) has ... as having "high normal" systolic blood pressure through,traditional ...
... 28 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ... oral and,poster presentations on its Cobalamin(TM) technology ... to Clinical Practice, taking,place from May 26-28 ... B12-Polymer Conjugates as Constructs for Targeted Tumor ...
Cached Medicine Technology:New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk 2New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk 3Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium 2Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium 3
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
... USS Sports Medicine POLYSORB Meniscal Stapler XLS ... two resorbable legs of the staple. The ... tissue, specifically the meniscus. The staple is ... derivative of lactic acid and glycolic acids. ...
Medicine Products: